Considering the heterogeneity observed in patients, we firstly studied the expression of CDH3 in a total of 12 GBM in vitro cell models, including six GBM cell lines and six patient‐derived cultures (Fig. S2). This evidence concerns the gene CDH3 and glioblastoma.